Date | Code | Name | Shareholder | Reason for disclosure | No. of Shares involved (Holding Position) | Average Price | No. of shares interested | % of issued share capital | |
10/01/2025 | 02186 | LUYE PHARMA | Shorea LBG | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | ||
10/01/2025 | 02186 | LUYE PHARMA | Luye Pharma Holdings Ltd. | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 229,317,950(S) | 33.53 6.10 | ||
10/01/2025 | 02186 | LUYE PHARMA | Shorea LBG | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | ||
10/01/2025 | 02186 | LUYE PHARMA | LuYe Pharmaceutical Investment Co., Ltd. | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | ||
10/01/2025 | 02186 | LUYE PHARMA | Luye Pharma Holdings Ltd. | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | ||
10/01/2025 | 02186 | LUYE PHARMA | Luye Life Sciences Group Ltd | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | ||
10/01/2025 | 02186 | LUYE PHARMA | Nelumbo Investments Limited | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | ||
10/01/2025 | 02186 | LUYE PHARMA | LuYe Pharmaceutical International Co., Ltd. | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | ||
10/01/2025 | 02186 | LUYE PHARMA | Ginkgo (PTC) Limited | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | ||
10/01/2025 | 02186 | LUYE PHARMA | Nelumbo Investments Limited | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 229,317,950(S) | 33.53 6.10 | ||
10/01/2025 | 02186 | LUYE PHARMA | Ginkgo (PTC) Limited | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 229,317,950(S) | 33.53 6.10 | ||
10/01/2025 | 02186 | LUYE PHARMA | Shorea LBG | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 229,317,950(S) | 33.53 6.10 | ||
10/01/2025 | 02186 | LUYE PHARMA | LuYe Pharmaceutical Investment Co., Ltd. | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 229,317,950(S) | 33.53 6.10 | ||
10/01/2025 | 02186 | LUYE PHARMA | Luye Pharma Holdings Ltd. | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 229,317,950(S) | 33.53 6.10 | ||
10/01/2025 | 02186 | LUYE PHARMA | LuYe Pharmaceutical International Co., Ltd. | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 229,317,950(S) | 33.53 6.10 | ||
10/01/2025 | 02186 | LUYE PHARMA | Luye Life Sciences Group Ltd | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 229,317,950(S) | 33.53 6.10 | ||
10/01/2025 | 02186 | LUYE PHARMA | Liu Dianbo | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | ||
10/01/2025 | 00916 | CHINA LONGYUAN | BlackRock, Inc. | 1313(L) | 680,000(L) | 167,118,041(L) 24,727,000(S) | 5.04 0.75 | ||
10/01/2025 | 02186 | LUYE PHARMA | Liu Dianbo | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | ||
10/01/2025 | 03889 | GLOBAL SWEET | 1213(L) | 260,313,000(L) | 13.48 | ||||
10/01/2025 | 09880 | UBTECH ROBOTICS | Qiming GP IV, L.P. | 1201(L) | -153,300(L) | HKD46.722(L) | 22,277,860(L) | 6.99 | |
10/01/2025 | 02338 | WEICHAI POWER | JPMorgan Chase & Co. | 1201(L) | -8,740,088(L) | HKD12.824(L) | 133,705,161(L) 10,508,323(S) 67,515,263(P) | 6.88 0.54 3.47 | |
10/01/2025 | 09909 | POWERLONG CM | Hoi Wa Fong | 1711(L) | -5,130,000(L) | 19,942,000(L) | 3.10 | ||
10/01/2025 | 02359 | WUXI APPTEC | JPMorgan Chase & Co. | 1402(S) | +4,785,872(S) | 37,702,343(L) 17,995,497(S) 14,259,243(P) | 9.74 4.64 3.68 | ||
10/01/2025 | 03968 | CM BANK | 1001(L) | +1,892,500(L) | HKD38.330(L) | 230,140,000(L) | 5.01 | ||
10/01/2025 | 00576 | ZHEJIANGEXPRESS | BlackRock, Inc. | 1313(L) | 134,000(L) | 110,304,312(L) 39,328,000(S) | 5.57 1.99 | ||
10/01/2025 | 01846 | EUROEYES | Braun Markus | 1711(L) | 0(L) | 283,000(L) | 0.09 | ||
10/01/2025 | 02186 | LUYE PHARMA | Luye Life Sciences Group Ltd | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | ||
10/01/2025 | 00629 | YUE DA INTL | Ji Hulin | 1705(L) | +166,666(L) | 166,666(L) | 0.01 | ||
10/01/2025 | 00095 | LVGEM CHINA | China Construction Bank Corporation | 1004(L) | +459,788,886(L) | 538,288,886(L) | 9.62 | ||
10/01/2025 | 00095 | LVGEM CHINA | Chan Tak Ho | 1307(L) | 459,788,886(L) | 1,166,789,698(L) | 20.84 | ||
10/01/2025 | 00681 | CHI PEOPLE HOLD | RENOWN CITY HOLDINGS LIMITED | 1102(L) | +2,000,000(L) | HKD0.024(L) | 3,734,904,762(L) | 41.80 | |
10/01/2025 | 00083 | SINO LAND | Ng Chee Siong | 1101(L) | +20,000(L) | HKD7.670(L) | 5,429,735,839(L) | 60.23 | |
10/01/2025 | 01952 | EVEREST MED-B | C-Bridge Investment Everest Limited | 1201(L) | -9,532,000(L) | 40,468,000(L) | 12.39 | ||
10/01/2025 | 01952 | EVEREST MED-B | C-Bridge Healthcare Fund II, L.P. | 1201(L) | -10,260,000(L) | 42,517,778(L) | 13.02 | ||
10/01/2025 | 01952 | EVEREST MED-B | C-Bridge Healthcare Fund GP II, L.P. | 1201(L) | -10,260,000(L) | 42,517,778(L) | 13.02 | ||
10/01/2025 | 02318 | PING AN | BlackRock, Inc. | 1313(L) | 3,084,000(L) | 429,480,761(L) 3,942,500(S) | 5.77 0.05 | ||
10/01/2025 | 00035 | FE CONSORT INTL | Chiu David | 1101(L) | +398,000(L) | HKD0.891(L) | 1,692,050,761(L) | 55.75 | |
10/01/2025 | 08622 | HUAKANG BIOMED | Crystal Grant Limited | 1710(L) | 138,672,000(L) | 27.71 | |||
10/01/2025 | 08622 | HUAKANG BIOMED | Crystal Grant Limited | 1201(L) | -138,672,000(L) | 0(L) | 0.00 | ||
1 2 3 4 5 6 7 8 9 10 |
Remark: | (L) - Long Position, (S) - Short Position, (P) Lending; |